Literature DB >> 25042215

Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective.

Maarten J G Leening1, Ewout W Steyerberg, Ben Van Calster, Ralph B D'Agostino, Michael J Pencina.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25042215     DOI： 10.1002/sim.6133

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  20 in total

1.  Complement C3a levels and misinterpretation of classifier technology.

Authors:  Mario Petretta
Journal:  Inflamm Res       Date:  2016-12-07       Impact factor: 4.575

Review 2.  Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy.

Authors:  Laura H Mariani; Matthias Kretzler
Journal:  Nephrol Dial Transplant       Date:  2015-06       Impact factor: 5.992

3.  Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Authors:  Nicholas J Taylor; Nandita Mitra; Lu Qian; Marie-Françoise Avril; D Timothy Bishop; Brigitte Bressac-de Paillerets; William Bruno; Donato Calista; Francisco Cuellar; Anne E Cust; Florence Demenais; David E Elder; Anne-Marie Gerdes; Paola Ghiorzo; Alisa M Goldstein; Thais C Grazziotin; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas K Hayward; Marko Hocevar; Veronica Höiom; Elizabeth A Holland; Christian Ingvar; Maria Teresa Landi; Gilles Landman; Alejandra Larre-Borges; Graham J Mann; Eduardo Nagore; Håkan Olsson; Jane M Palmer; Barbara Perić; Dace Pjanova; Antonia L Pritchard; Susana Puig; Helen Schmid; Nienke van der Stoep; Margaret A Tucker; Karin A W Wadt; Xiaohong R Yang; Julia A Newton-Bishop; Peter A Kanetsky
Journal:  J Am Acad Dermatol       Date:  2019-02-05       Impact factor: 11.527

4.  Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease.

Authors:  Ye-Xuan Cao; Hui-Wen Zhang; Jing-Lu Jin; Hui-Hui Liu; Yan Zhang; Rui-Xia Xu; Ying Gao; Yuan-Lin Guo; Cheng-Gang Zhu; Qi Hua; Yan-Fang Li; Raul D Santos; Na-Qiong Wu; Jian-Jun Li
Journal:  J Lipid Res       Date:  2020-07-08       Impact factor: 5.922

5.  Simpson's paradox in the integrated discrimination improvement.

Authors:  J Chipman; D Braun
Journal:  Stat Med       Date:  2016-01-05       Impact factor: 2.373

6.  AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin.

Authors:  Marine Flechet; Fabian Güiza; Miet Schetz; Pieter Wouters; Ilse Vanhorebeek; Inge Derese; Jan Gunst; Isabel Spriet; Michaël Casaer; Greet Van den Berghe; Geert Meyfroidt
Journal:  Intensive Care Med       Date:  2017-01-27       Impact factor: 17.440

7.  Prediction of Incident Major Osteoporotic and Hip Fractures by Trabecular Bone Score (TBS) and Prevalent Radiographic Vertebral Fracture in Older Men.

Authors:  John T Schousboe; Tien Vo; Brent C Taylor; Peggy M Cawthon; Ann V Schwartz; Douglas C Bauer; Eric S Orwoll; Nancy E Lane; Elizabeth Barrett-Connor; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2015-10-21       Impact factor: 6.741

8.  Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator.

Authors:  Helen M Johnson; William Irish; Nasreen A Vohra; Jan H Wong
Journal:  Breast Cancer Res Treat       Date:  2021-02-20       Impact factor: 4.872

Review 9.  Clinical risk reclassification at 10 years.

Authors:  Nancy R Cook; Olga V Demler; Nina P Paynter
Journal:  Stat Med       Date:  2017-12-10       Impact factor: 2.373

10.  Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes.

Authors:  Zheng Wang; Yu Cheng; Eric C Seaberg; James T Becker
Journal:  Biostatistics       Date:  2020-02-21       Impact factor: 5.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.